Yoshiya Horimoto

47PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersJapanese languageGenomics and transcriptomicsPopular and genre literature
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jun 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

|May 18, 2026
Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing.

|Mar 13, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data Analysis.

Moe Itakura, Yoshiya Horimoto, Yumiko Ushiyama

|Jan 31, 2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.

Yuri Takamatsu, Yoshiya Horimoto, Yasuo Miyoshi

|Jan 05, 2026
Organ-Specific Clinicopathological Features That Are Associated With Post-Relapse Survival of Metastatic Breast Cancer in Japanese Women: A Multicenter Cohort Study.

Yoichi Koyama, Yoshiya Horimoto, Akimitsu Yamada

|Dec 29, 2025
Bridging across the pacific: overview of the 33rd annual meeting of the Japanese breast cancer society.

Hiroki Kusama, Yoshiya Horimoto, Kayo Adachi

Pageof 8

Frequent Collaborators

11 joint publications

Takashi Ishikawa

9 joint publications

Junichiro Watanabe

6 joint publications

Yumiko Ishizuka

5 joint publications

Hiroshi Kaise